Studies on the Injectable Solution of Colistin Sulfate and Its Pharmacokinetics

Xi Xiao
2003-01-01
Abstract:The injection of colistin sulfate contains colistin sulfate, local anaesthesia, antioxygen and other additaments. The experimental results showed that the novel preparation was stable either in heat or in light. The term of validity of the preparation was 2 years at room temperature. The preparation containing 25.0 mg·ml -1 of colistin sulfate showed no local tissue irritation, but the concentration of 50.0 mg·ml -1 showed obvious local tissue irritation. Result of acute toxicity test showed that the LD 50 of intramuscular injection in mice was 38.72 mg·kg -1 , and oral LD 50 was 431.39 mg·kg -1 . The evidence of neurotoxicity was observed in mice in the acute toxicity test. A dose of 10.0 mg·kg -1 or 15.0 mg·kg -1 BW was adminidtered intramuscularly to piglet once daily for 5 days. No changes were detected in the piglet body except for the slight epithelial tissue's granular degenerations in the kidney and liver at the dose rate of 10.0 mg·kg -1 . At the dose rate of 15.0 mg·kg -1 , the obvious neurotoxicity was observed at 4-5 days. The epithelial tissues in the kidney and liver showed moderate granular degenerations, especial tubuli renales cells. The result of blood cell's morphosis indexes showed normal. With relation to liver's function, the indexes went beyond the normal scope. Otherwise with relation to kidney's function, the indexes showed mostly normal. Injection was separately administered into muscle(IM) in pigs with the doses of 2.5 and 5.0 mg·kg -1 BW, whose C max were 3.73±0.28 and 6.40±0.18 μg·ml -1 ; T max were 32±1.5 and 34±1.8 min; t 1/2β were 256±14 and 264±29 min;injection was administered into aural vein(IV) with the dose of 2.5 mg·kg -1 BW, whose t 1/2β was 251±13 min. Examples of the experimentally determined serum concentration of colistin sulfate generated two exponential model with first order absorption. The mean absolutely bioavailability coefficient of 2.5 and 5.0 mg·kg -1 BW (IM) were 98.30% and 88.54%. The high bioavailability and the long maintaining time of the valid blood drug concentration show that the injection is good for IM in pigs, the recommended dose is 2.5 mg·kg -1 BW, twice daily.
What problem does this paper attempt to address?